Harwood, Adrian John ORCID: https://orcid.org/0000-0003-3124-5169 2011. Prolyl oligopeptidase, inositol phosphate signalling and lithium sensitivity. CNS & Neurological Disorders - Drug Targets 10 (3) , pp. 333-339. 10.2174/187152711794653779 |
Official URL: http://dx.doi.org/10.2174/187152711794653779
Abstract
Inhibition of prolyl oligopeptidase (PO) elevates inositol phosphate (IP) signalling and reduces cell sensitivity to lithium (Li+). This review discusses recent evidence that shows PO acts via the multiple inositol polyphosphate phosphatase (MIPP) to regulate gene expression. As a consequence, PO inhibition causes both a transient, rapid increase in I(1,4,5)P3 and a long-term elevation of IP signalling. This pathway is evolutionary conserved, being present in both the social amoeba Dictyostelium and human cell systems, and has potential implications for mental health.
Item Type: | Article |
---|---|
Date Type: | Publication |
Status: | Published |
Schools: | Biosciences Neuroscience and Mental Health Research Institute (NMHRI) |
Subjects: | Q Science > Q Science (General) |
Uncontrolled Keywords: | Bipolar mood disorder; Dictyostelium; inositol phosphate signalling; lithium; multiple inositol polyphosphate phosphatase; prolyl oligopeptidase; IMPase; LY294002; GSK-3; MIPP; ISYNA1 |
Publisher: | Bentham Science |
ISSN: | 1871-5273 |
Last Modified: | 20 Oct 2022 07:50 |
URI: | https://orca.cardiff.ac.uk/id/eprint/26554 |
Citation Data
Cited 16 times in Scopus. View in Scopus. Powered By Scopus® Data
Actions (repository staff only)
Edit Item |